49 related articles for article (PubMed ID: 31503268)
41. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis.
Dey P; Kim JB; Chitchumroonchokchai C; Li J; Sasaki GY; Olmstead BD; Stock KL; Thomas-Ahner JM; Clinton SK; Bruno RS
Food Funct; 2019 Oct; 10(10):6351-6361. PubMed ID: 31503268
[TBL] [Abstract][Full Text] [Related]
42. Anti-inflammatory activities of green tea catechins along the gut-liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies.
Hodges JK; Sasaki GY; Bruno RS
J Nutr Biochem; 2020 Nov; 85():108478. PubMed ID: 32801031
[TBL] [Abstract][Full Text] [Related]
43. Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma.
Márquez-Quiroga LV; Arellanes-Robledo J; Vásquez-Garzón VR; Villa-Treviño S; Muriel P
Biochem Pharmacol; 2022 Jan; 195():114845. PubMed ID: 34801522
[TBL] [Abstract][Full Text] [Related]
44. Diethylnitrosamine-induced liver tumorigenesis in mice.
Schulien I; Hasselblatt P
Methods Cell Biol; 2021; 163():137-152. PubMed ID: 33785162
[TBL] [Abstract][Full Text] [Related]
45. The effect of green tea extract on fat oxidation at rest and during exercise: evidence of efficacy and proposed mechanisms.
Hodgson AB; Randell RK; Jeukendrup AE
Adv Nutr; 2013 Mar; 4(2):129-40. PubMed ID: 23493529
[TBL] [Abstract][Full Text] [Related]
46.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
47.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
48.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
